BlackRock Health Sciences Trust Capital Reinvestment Ratio

Latest as of December 2024: 0.00x

BlackRock Health Sciences Trust capital reinvestment ratio. BlackRock Health Sciences Trust (BME) has a Capital Reinvestment Ratio of 0.00x as of December 2024, meaning it reinvests 0% of its operating cash flow ($959.34K) in capital expenditures ($5.00). Check BME capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.00x
Capex / Operating Cash Flow

Operating Cash Flow

$959.34K
USD

Capital Expenditures

$5.00
USD

Data as of

Dec 2024
Most recent filing

Capital Reinvestment Ratio of BlackRock Health Sciences Trust (2023–2023)

Capital reinvestment ratio of BlackRock Health Sciences Trust from 2023 to 2023. This chart tracks BlackRock Health Sciences Trust's Capital Reinvestment Ratio across 1 annual periods. Also explore BME year-over-year net asset growth to track the company's year-over-year net asset growth rate.

BlackRock Health Sciences Trust Capital Reinvestment Ratio by Year (2023–2023)

BlackRock Health Sciences Trust capital reinvestment ratio by year from 2023 to 2023. For the full cash flow conversion analysis, see BlackRock Health Sciences Trust cash flow conversion.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2023 0.00x $32.02 Million $3.00 —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow